Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy. [electronic resource]
Producer: 20080826Description: 1202-7; discussion 1207-10 p. digitalISSN:- 1530-0358
- Adult
- Antibodies, Monoclonal -- adverse effects
- Case-Control Studies
- Chi-Square Distribution
- Colitis, Ulcerative -- drug therapy
- Combined Modality Therapy
- Female
- Gastrointestinal Agents -- adverse effects
- Humans
- Infliximab
- Logistic Models
- Male
- Postoperative Complications -- etiology
- Proctocolectomy, Restorative
- Retrospective Studies
- Risk
- Statistics, Nonparametric
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.